Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of angelicin and of its structural analogues for the treatment of thalassemia

Use of angelicin and of its structural analogues for the treatment of thalassemia

US Patent 7572827 · Granted Aug 11, 2009

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Isoxazole derivatives as inducers of fetal hemoglobin in erythroid precursor cel2021
Isoxazole derivatives as inducers of fetal hemoglobin in erythroid precursor cel2021
Diagnostic and therapeutic application of CTL and NK functionally selected cells2016
Compounds for use in the treatment of disorders that are ameliorated by inhibiti2016
Method of making and administering quinoline derivatives as anti-cancer agents2016
Trimethylangelicin as CFTR corrector in bronchial epithelial cells2016
Double-stranded synthetic oligonucleotides useful for inducing apoptosis of oste2010
Use of rapamycin and structural analogues thereof2009
Use of rapamycin and structural analogues thereof2009
Use of rapamycin and structural analogues thereof2009
Heterocyclic and benzoheterocyclic polyamides structurally related to the natura2008
Heterocyclic and benzoheterocyclic polyamides structurally related to the natura2008